Published in J Natl Cancer Inst on August 01, 1983
Carcinogen-induced depletion of cutaneous Langerhans cells. Br J Cancer (1985) 0.96
Generation of natural killer cells from bone marrow precursors in vitro. Immunology (1986) 0.84
Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J (1995) 1.54
Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes. J Natl Cancer Inst (1979) 1.49
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med (1995) 1.30
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29
Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol (1997) 1.29
Cervicovaginal epithelium: its origin and development. Am J Obstet Gynecol (1973) 1.24
Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci U S A (1991) 1.22
In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors. Proc Natl Acad Sci U S A (1996) 1.21
Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol (1992) 1.17
Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Immunology (1993) 1.13
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. J Immunol (1987) 1.13
Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer (1993) 1.11
Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology (1994) 1.10
Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol (1991) 1.09
Late effects in the vaginal and cervical epithelia after injections of diethylstilbestrol into neonatal mice. Am J Obstet Gynecol (1975) 1.08
T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol (1995) 1.07
Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator. J Immunol (1985) 1.06
Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. Eur J Immunol (1996) 1.05
Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells. Cancer Immunol Immunother (1993) 1.03
Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. Immunology (1990) 1.03
Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo. Proc Natl Acad Sci U S A (1995) 1.03
Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J Clin Oncol (1997) 1.02
Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol Today (1991) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunol Immunother (1995) 0.99
Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release. Cell Immunol (1996) 0.99
Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses. Am J Pathol (1997) 0.98
Estrogen, vaginal cancer, and vaginal development. Am J Obstet Gynecol (1972) 0.97
Linomide, a novel immunomodulator that prevents death in four models of septic shock. Eur J Immunol (1993) 0.95
Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma. Cancer Res (1986) 0.95
Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol (1988) 0.95
The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets. Scand J Immunol (1992) 0.94
Effect of estrogen and corticosterone on the lymphoid system in neonatal mice. Exp Mol Pathol (1978) 0.93
Effects of neonatal exposure to diethylstilbestrol on early mouse embryo development in vivo and in vitro. Biol Reprod (1991) 0.92
Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis. Arch Toxicol (1984) 0.92
Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity. Eur J Immunol (1991) 0.92
Superantigen-induced anergy in cytotoxic CD8+ T cells. J Immunol (1995) 0.92
Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells. Cell Immunol (1990) 0.91
Genetically engineered superantigens as tolerable antitumor agents. Proc Natl Acad Sci U S A (1997) 0.91
Linomide inhibits programmed cell death of peripheral T cells in vivo. Eur J Immunol (1994) 0.91
Effects of hormone-cytostatic complexes on the rat ventral prostate in vivo and in vitro. Vitam Horm (1975) 0.90
Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol. J Immunol (1980) 0.89
Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. Immunology (1993) 0.89
Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth. Int J Cancer (1998) 0.88
The role of B7-1 and LFA-3 in costimulation of CD8+ T cells. J Immunol (1997) 0.88
Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J Biol Chem (1993) 0.88
Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. J Immunol (1996) 0.87
Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling. J Immunol (1993) 0.86
Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines. Cancer Res (1995) 0.86
Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol. Cancer Res (1981) 0.86
Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity. J Immunol (1996) 0.86
Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens. J Immunol (1998) 0.85
Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. J Immunol (1994) 0.85
Effects of diethylstilbestrol (DES) medication during pregnancy: report from a symposium at the 10th international congress of ISPOG. J Psychosom Obstet Gynaecol (1993) 0.85
Tumor-reactive superantigens suppress tumor growth in humanized SCID mice. Int J Cancer (1995) 0.85
Decreased and disproportionate T-cell population in adult mice after neonatal exposure to diethylstilbestrol. Cell Immunol (1980) 0.85
Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus. Infect Immun (1995) 0.85
Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Blood (1993) 0.84
The development of atypical epithelium in the mouse uterine cervix and vaginal fornix after neonatal oestradiol treatment. Br J Exp Pathol (1969) 0.84
Generation of natural killer cells from bone marrow precursors in vitro. Immunology (1986) 0.84
A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies. Blood (1997) 0.84
Alterations of antibody response in female mice after neonatal exposure to diethylstilbestrol. J Immunol (1980) 0.83
Independent regulation of IFN-gamma and tumor necrosis factor by IL-1 in human T helper cells. J Immunol (1990) 0.83
Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res (1981) 0.83
Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections. J Immunol Methods (1997) 0.83
Delayed hypersensitivity response to oxazolone in neonatally estrogenized mice. Cancer Lett (1978) 0.82
T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens. Cancer Immunol Immunother (1993) 0.82
Immune response during tumor therapy with antibody-superantigen fusion proteins. Int J Cancer (1996) 0.82
Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain. J Immunol (1997) 0.82
Effects of the novel immunomodulator LS 2616 on the delayed-type hypersensitivity reaction to Bordetella pertussis in the rat. Immunopharmacology (1986) 0.82
Genotoxic effects of estrogens in epithelial cells from the neonatal mouse uterine cervix: modifications by metabolic modifiers. Teratog Carcinog Mutagen (1989) 0.82
Mitotic rate and autoradiographic studies on the derivation and differentiation of the epithelium in the mouse vaginal anlage. Acta Anat (Basel) (1965) 0.82
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis. J Neuroimmunol (1997) 0.82
T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant. Immunology (1997) 0.81
Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother (1991) 0.81
Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. Natl Cancer Inst Monogr (1979) 0.81
Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules. Scand J Immunol (1993) 0.81
Exposure of neonatal female mice to diethylstilbestrol persistently impairs NK activity through reduction of effector cells at the bone marrow level. Immunopharmacology (1984) 0.81
Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR. J Immunol (1997) 0.81
A case of testicular feminization with chromosome mosaicism. Acta Obstet Gynecol Scand (1965) 0.81
Induction of conditions leading to cancer in the genital tract by estrogen during the differentiation phase of the genital epithelium. Adv Biosci (1974) 0.81
Structural and functional changes in ovaries from adult mice treated with diethylstilboestrol in the neonatal period. J Reprod Fertil (1985) 0.80
Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug. Diabetologia (1994) 0.80
Augmentation of natural killer cell activity after arterial embolization of renal carcinomas. Cancer Res (1982) 0.80
Ovarian reproductive function after exposure to diethylstilbestrol in neonatal life. Biol Reprod (1990) 0.80
Effects of diethylstilbestrol on human natural killer cells in vitro. Immunopharmacology (1984) 0.80
A simple and rapid method to distinguish between rosettes and non-specific aggregation of erythrocytes in the rosette assay for human T-lymphocytes. J Immunol Methods (1977) 0.80
Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors. J Immunol (1995) 0.80
Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding. Mol Cell Biol (1997) 0.80
Abnormalities in the adult mouse vagina after neonatal estradiol treatment. Biol Neonat (1968) 0.79
Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells. Cancer Immunol Immunother (1995) 0.79
Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity. Cancer Immunol Immunother (1994) 0.79